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In This IssueReview Focus: Therapeutic Discovery
MERKLE AND EGGAN, PAGE 656, ENGLE AND PUPPALA, PAGE 669, YU ET AL., PAGE 678, AND
GARBERN AND LEE, PAGE 689
This issue features a series of Perspectives on therapeutic discovery with stem
cells. Two of the articles broadly discuss the challenges and considerations for
incorporating human pluripotent stem cells into disease modeling and drug
discovery efforts, respectively, and the other two focus more specifically on
therapeutic translation of stem cell technologies for treating either neurological
or cardiac disease. Read the editorial by Deborah Sweet in this issue to find out
more about other activities Cell Stem Cell has planned to cover this important
topic.
A Positive Role for ROS in SSC Self-Renewal
MORIMOTO ET AL., PAGE 774
Knockout of the NADPH oxidase1 revealed an indispensable role for
physiological levels of reactive oxygen species in spermatogonial stem cell
self-renewal.ROS and NF-kB Drive Colorectal Cancer Initiation
MYANT ET AL., PAGE 761
This study demonstrates Rac1-mediated ROS production and NF-kB activation is required for Lgr5 stem cell expansion and
colorectal cancer initiation following loss of the Apc gene. Preview by Pelicci.
Stem-Cell-Based Drug Screen IDs a Potential Therapeutic for ALS
YANG ET AL., PAGE 713
Kenpaullone was identified as a strong hit in an ESC-derived motor neuron survival screen. This compound acts as a dual
kinase inhibitor and is effective on various mouse and human ALS motor neuron lines. Preview by Lee.
2-in-1: a Shared Disease Mechanism for Disparate Phenotypes
Revealed by hPSCs
TULPULE ET AL., PAGE 727
hESC/iPSC models of Shwachman-Diamond syndrome reveal elevated protease activity as a common underlying
mechanism for dysfunction in pancreatic and hematopoietic lineages.
KDR Is a Functional Receptor Instructing Liver Development
GOLDMAN ET AL., PAGE 748
The receptor KDR (VEGFR2), normally associated with mesoderm derivatives, identifies an endoderm-derived hepatic
progenitor in hESCs that is also present in fetal mouse and human liver.
3D Organization of Pluripotency
APOSTOLOU ET AL., PAGE 699
The Nanog promoter interacts with the rest of the genome in an unexpectedly complex pluripotency-specific chromatin
interaction network that depends on Mediator and cohesins.
Bone Matrix Contributions to the HSC Niche
ASADA ET AL., PAGE 737Bone-embedded osteocytes respond rapidly to G-CSF and regu-
late hematopoietic stem/progenitor cell mobilization.
Adenoviral Delivery of Neurogenesis
Stimulators Slows HD Progression
BENRAISS ET AL., PAGE 787
Expression of BDNF and noggin using adenoviral vectors induces
neurogenesis that slows motor deterioration and extends life
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